Edit ID | Edit Comment | Time | |
---|---|---|---|
402506 | add tiering information | 12/13/2018 4:07 PM |
This mutation is recognized as gain of function mutation. Tumor with this mutation responds to neratinib, a type of TKI which is against HER2 and EGFR.
This mutation is recognized as gain of function mutation. Tumor with this mutation responds to neratinib, a type of TKI which is against HER2 and EGFR.